BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26517400)

  • 1. Molecular Characterization of Acute Cellular Rejection Occurring During Intentional Immunosuppression Withdrawal in Liver Transplantation.
    Bonaccorsi-Riani E; Pennycuick A; Londoño MC; Lozano JJ; Benítez C; Sawitzki B; Martínez-Picola M; Bohne F; Martínez-Llordella M; Miquel R; Rimola A; Sánchez-Fueyo A
    Am J Transplant; 2016 Feb; 16(2):484-96. PubMed ID: 26517400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of immunosuppression minimization and withdrawal early after liver transplantation.
    Shaked A; DesMarais MR; Kopetskie H; Feng S; Punch JD; Levitsky J; Reyes J; Klintmalm GB; Demetris AJ; Burrell BE; Priore A; Bridges ND; Sayre PH
    Am J Transplant; 2019 May; 19(5):1397-1409. PubMed ID: 30506630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.
    Perito ER; Martinez M; Turmelle YP; Mason K; Spain KM; Bucuvalas JC; Feng S
    Am J Transplant; 2019 May; 19(5):1545-1551. PubMed ID: 30614623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated.
    Taubert R; Danger R; Londoño MC; Christakoudi S; Martinez-Picola M; Rimola A; Manns MP; Sánchez-Fueyo A; Jaeckel E
    Am J Transplant; 2016 Apr; 16(4):1285-93. PubMed ID: 26603835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the liver graft.
    Celaj S; Levitsky J
    Curr Opin Organ Transplant; 2021 Feb; 26(1):17-22. PubMed ID: 33278149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients.
    Fairfield C; Penninga L; Powell J; Harrison EM; Wigmore SJ
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD007606. PubMed ID: 29630730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?
    Rebollo-Mesa I; Nova-Lamperti E; Mobillo P; Runglall M; Christakoudi S; Norris S; Smallcombe N; Kamra Y; Hilton R; ; Bhandari S; Baker R; Berglund D; Carr S; Game D; Griffin S; Kalra PA; Lewis R; Mark PB; Marks S; Macphee I; McKane W; Mohaupt MG; Pararajasingam R; Kon SP; Serón D; Sinha MD; Tucker B; Viklický O; Lechler RI; Lord GM; Hernandez-Fuentes MP
    Am J Transplant; 2016 Dec; 16(12):3443-3457. PubMed ID: 27328267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Rasmussen DL; Wiesner RH; Charlton MR
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers of acute rejection and graft acceptance in liver transplantation.
    Germani G; Rodriguez-Castro K; Russo FP; Senzolo M; Zanetto A; Ferrarese A; Burra P
    World J Gastroenterol; 2015 Jan; 21(4):1061-8. PubMed ID: 25632178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressed calcineurin-dependent gene expression identifies lung allograft recipients at increased risk of infection.
    Greenland JR; Chong T; Wang AS; Martinez E; Shrestha P; Kukreja J; Hays SR; Golden JA; Singer JP; Tang Q
    Am J Transplant; 2018 Aug; 18(8):2043-2049. PubMed ID: 29673076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Shaked A; Chang BL; Barnes MR; Sayre P; Li YR; Asare S; DesMarais M; Holmes MV; Guettouche T; Keating BJ
    Hepatology; 2017 Jan; 65(1):269-280. PubMed ID: 27533743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
    Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
    J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis E virus genotype 3 is a common finding in liver-transplanted patients undergoing liver biopsy for elevated liver enzymes with a low De Ritis ratio and suspected acute rejection: A real-world cohort.
    Darstein F; Häuser F; Straub BK; Wenzel JJ; Conradi R; Mittler J; Lang H; Galle PR; Zimmermann T
    Clin Transplant; 2018 Nov; 32(11):e13411. PubMed ID: 30230607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weaning of immunosuppression in liver transplant recipients.
    Mazariegos GV; Reyes J; Marino IR; Demetris AJ; Flynn B; Irish W; McMichael J; Fung JJ; Starzl TE
    Transplantation; 1997 Jan; 63(2):243-9. PubMed ID: 9020325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.
    Shi XL; de Mare-Bredemeijer EL; Tapirdamaz Ö; Hansen BE; van Gent R; van Campenhout MJ; Mancham S; Litjens NH; Betjes MG; van der Eijk AA; Xia Q; van der Laan LJ; de Jonge J; Metselaar HJ; Kwekkeboom J
    Am J Transplant; 2015 Sep; 15(9):2431-42. PubMed ID: 25943855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down regulation of protective genes is associated with cellular and antibody-mediated rejection.
    Lin-Wang HT; Cipullo R; Dinkhuysen JJ; Finger MA; Rossi JM; Correia EB; Hirata MH
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28752907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced B Cell Alloantigen Presentation and Its Epigenetic Dysregulation in Liver Transplant Rejection.
    Ningappa M; Ashokkumar C; Higgs BW; Sun Q; Jaffe R; Mazariegos G; Li D; Weeks DE; Subramaniam S; Ferrell R; Hakonarson H; Sindhi R
    Am J Transplant; 2016 Feb; 16(2):497-508. PubMed ID: 26663361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.